P
Posos
Developing artificial intelligence-based solutions, capable of immediately answering questions about medications
About Posos
Posos operates as a global medication data platform, delivering real-time, actionable drug information directly within Electronic Medical Records (EMRs). The company's core technology is centered around artificial intelligence algorithms that are capable of converting free-text, voice, and image-based prescriptions into structured, FHIR-interoperable data. This functionality is designed to streamline the prescription process for healthcare professionals, including doctors and pharmacists, by providing instant analysis of prescriptions against patient data and established medical guidelines.
Read full description
The platform's database is both multilingual and multi-country, and the medical data is structured using SNOMED, which allows for the integration of additional features such as speech-to-text, predictive health analytics, and dosing suggestions. The business model appears to be B2B, providing its AI-powered services and data to enhance the capabilities of existing EHR systems and other healthcare solutions. By automating and securing the medication prescription and reconciliation circuit, Posos aims to reduce administrative tasks and improve patient safety. The development of the platform has been guided by a scientific committee of medical and pharmaceutical professionals.
At a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Paris, France
- Employees
- 58
- Open positions
- None listed
- Dealroom signal
- 60.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Health Information, Medical Data Systems, Core AI, Medical Data
- Technology
- Artificial Intelligence, Mobile app
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Oct 2022 | $11M | $43M | Captech Sante & Nord France Amorcage · AG2R LA MONDIALE · Sofiouest · CapHorn | ↗ |
| SUPPORT PROGRAMOther financing | May 2020 | $44K | — | EIT Health | — |
Growth signals
Latest recorded traffic for Posos is 13K monthly website visits, up 30% over the last three months. Posos's team declined 13.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Anaxago
Series A6 investors entered at this stage
- CACaptech Sante & Nord France Amorcage
AG2R LA MONDIALE
Sofiouest
CapHorn
Caisse des Dépôts- MHMelusine Holding
Other known investors3 additional known investors
EIT Health
Finorpa
Station F
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Posos on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Posos’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.